Literature DB >> 19776126

Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

Sungwook Lee1, Shuhei Sakakibara, Seiji Maruo, Bo Zhao, Michael A Calderwood, Amy M Holthaus, Chiou-Yan Lai, Kenzo Takada, Elliott Kieff, Eric Johannsen.   

Abstract

B lymphocytes converted into lymphoblastoid cell lines (LCLs) by an Epstein-Barr virus that expresses a conditional EBNA3C require complementation with EBNA3C for growth under nonpermissive conditions. Complementation with relatively large EBNA3C deletion mutants identified amino acids (aa) 1 to 506 (which includes the RBP-Jkappa/CSL [RBP-Jkappa] binding domain) and 733 to 909 to be essential for LCL growth, aa 728 to 732 and 910 to 992 to be important for full wild-type (wt) growth, and only aa 507 to 727 to be unimportant (S. Maruo, Y. Wu, T. Ito, T. Kanda, E. D. Kieff, and K. Takada, Proc. Natl. Acad. Sci. USA 106:4419-4424, 2009). When mutants with smaller deletions were used, only aa 51 to 400 and 851 to 900 were essential for LCL growth; aa 447 to 544, 701 to 750, 801 to 850, and 901 to 992 were important for full wt growth; and aa 4 to 50, 401 to 450, 550 to 707, and 751 to 800 were unimportant. These data reduce the EBNA3C essential residues from 68% to 40% of the open reading frame. Point mutations confirmed RBP-Jkappa binding to be essential for wt growth and indicated that SUMO and CtBP binding interactions were important only for full wt growth. EBNA3C aa 51 to 150, 249 to 311, and 851 to 900 were necessary for maintaining LCL growth, but not RBP-Jkappa interaction, and likely mediate interactions with other key cell proteins. Moreover, all mutants null for LCL growth had fewer S+G(2)/M-phase cells at 14 days, consistent with EBNA3C interaction with RBP-Jkappa as well as aa 51 to 150, 249 to 311, and 851 to 900 being required to suppress p16(INK4A) (S. Maruo, Y. Wu, S. Ishikawa, T. Kanda, D. Iwakiri, and K. Takada, Proc. Natl. Acad. Sci. USA 103:19500-19505, 2006). We have confirmed that EBNA3C upregulates TCL1 and discovered that EBNA3C upregulates TCL1 through RBP-Jkappa, indicating a central role for EBNA3C interaction with RBP-Jkappa in mediating cell gene transcription.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776126      PMCID: PMC2786754          DOI: 10.1128/JVI.01403-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.

Authors:  R Touitou; M Hickabottom; G Parker; T Crook; M J Allday
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.

Authors:  Jeffrey Lin; Eric Johannsen; Erle Robertson; Elliott Kieff
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.

Authors:  B Zhao; C E Sample
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.

Authors:  L C Spender; G H Cornish; B Rowland; B Kempkes; P J Farrell
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

Authors:  G A Parker; R Touitou; M J Allday
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

7.  Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.

Authors:  Chitra Subramanian; Sameez Hasan; Martin Rowe; Michael Hottiger; Rama Orre; Erle S Robertson
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.

Authors:  Gerald Künstle; Jarmo Laine; Gaelle Pierron; Shin-ichiro Kagami Si; Hiroshi Nakajima; Francois Hoh; Christian Roumestand; Marc-Henri Stern; Masayuki Noguchi
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

9.  Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.

Authors:  Bharat G Bajaj; Masanao Murakami; Qiliang Cai; Subhash C Verma; Ke Lan; Erle S Robertson
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

10.  EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.

Authors:  Andrew Cooper; Eric Johannsen; Seiji Maruo; Ellen Cahir-McFarland; Diego Illanes; David Davidson; Elliott Kieff
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  22 in total

1.  Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.

Authors:  Hongfang Wang; James Zou; Bo Zhao; Eric Johannsen; Todd Ashworth; Hoifung Wong; Warren S Pear; Jonathan Schug; Stephen C Blacklow; Kelly L Arnett; Bradley E Bernstein; Elliott Kieff; Jon C Aster
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

2.  Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.

Authors:  Michael A Calderwood; Sungwook Lee; Amy M Holthaus; Stephen C Blacklow; Elliott Kieff; Eric Johannsen
Journal:  Virology       Date:  2011-03-26       Impact factor: 3.616

3.  Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.

Authors:  Anqi Wang; Rene Welch; Bo Zhao; Tram Ta; Sündüz Keleş; Eric Johannsen
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.

Authors:  Bo Zhao; Jessica C Mar; Seiji Maruo; Sungwook Lee; Benjamin E Gewurz; Eric Johannsen; Kristina Holton; Renee Rubio; Kenzo Takada; John Quackenbush; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.

Authors:  Stefanie C S Schmidt; Sizun Jiang; Hufeng Zhou; Bradford Willox; Amy M Holthaus; Peter V Kharchenko; Eric C Johannsen; Elliott Kieff; Bo Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-24       Impact factor: 11.205

6.  Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.

Authors:  Seiji Maruo; Bo Zhao; Eric Johannsen; Elliott Kieff; James Zou; Kenzo Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

7.  Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.

Authors:  Lenka Skalska; Robert E White; Melanie Franz; Michaela Ruhmann; Martin J Allday
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

8.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

9.  Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.

Authors:  Sizun Jiang; Bradford Willox; Hufeng Zhou; Amy M Holthaus; Anqi Wang; Tommy T Shi; Seiji Maruo; Peter V Kharchenko; Eric C Johannsen; Elliott Kieff; Bo Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

Review 10.  Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.

Authors:  Abhik Saha; Erle S Robertson
Journal:  Future Microbiol       Date:  2013-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.